Screener
Arcus Biosciences RCUS Access rights — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
| Line item | Over time | Point in time | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|---|---|
| Gilead Collaboration | ||||||
| License and development services | * | $8 | $152 | $15 | $172 | |
| R&D services | * | 4 | 2 | 6 | 5 | |
| Access rights | * | 21 | 6 | 24 | 11 | |
| Other | * | — | — | 3 | — | |
| Taiho Collaboration | ||||||
| License and development services | * | 4 | — | 6 | — | |
| License | * | 4 | — | 4 | — |
Item 1. Financial Statements
FAQ
- What is Arcus Biosciences's access rights — total revenues?
- Arcus Biosciences (RCUS) reported access rights — total revenues of $21M in Q2 2026.
- How has Arcus Biosciences's access rights — total revenues changed year-over-year?
- Arcus Biosciences's access rights — total revenues increased by 250.0% year-over-year, from $6M to $21M.
- What is the long-term trend for Arcus Biosciences's access rights — total revenues?
- Over 2 years (2022 to 2025), Arcus Biosciences's access rights — total revenues has grown at a -28.2% compound annual growth rate (CAGR), from $33M to $17M.
- What does access rights — total revenues mean?
- This metric represents the total revenue recognized from granting access rights, licenses, or intellectual property usage to third-party partners. It reflects the financial value generated from the commercialization or strategic out-licensing of proprietary technology and research assets. Monitoring this figure helps investors assess the company's ability to monetize its R&D pipeline through collaborative agreements.
Ask your AI about Arcus Biosciences's access rights — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude